MidhunMallaMD

Oncology • Birmingham, AL

Physician

Join to view full profile

Dr. Malla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Malla's full profile

Already have an account?

Office
1824 6th Avenue S
Birmingham, AL 35233
Phone+1 205-934-4011

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Creighton University School of Medicine (Phoenix)Residency, Internal Medicine, 2013 - 2016
Guntur Medical College NTRClass of 2011

Certifications & Licensure

AL State Medical License 2023 - 2025
IA State Medical License 2023 - 2025
WV State Medical License 2019 - 2025
OK State Medical License 2016 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer Start of enrollment: 2019 May 10
COMPLETED
PHASE3

Publications & Presentations

PubMed

BPI25-016: Real-World Outcomes of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Insights From a Single Center in the Deep South.
Todd William Mudd, Faris A Abby, Darryl Outlaw, Mehmet Akce, Bassel El-Rayes
Journal of the National Comprehensive Cancer Network. 2025-03-28
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01
5 citations
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.
Gregory P Botta, Maen Abdelrahim, Ronald L Drengler, Vasily N Aushev, Abdullah Esmail
The Oncologist. 2024-10-03

Lectures

Survival outcomes following cytoreductive nephrectomy (CN) in patients with metastatic renal cell sarcomas (MRCS).
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

NCCN Clinical Practice Guidelines in Oncology: 2023 UpdatesMay 19th, 2023
New Doctors Join WVU Medicine in Morgantown, MartinsburgJuly 2nd, 2019